CHAMPIONS ONCOLOGY, INC. Tax Adjustments, Settlements, and Unusual Provisions
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Tax Adjustments, Settlements, and Unusual Provisions of $181.00 thousand for the 12-month period ending 2025-04-30, per its 10-K filed 2026-07-27.
Financial Statements › Notes › Income Taxes
us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions · last filed 2026-07-27
- CHAMPIONS ONCOLOGY, INC. tax adjustments, settlements, and unusual provisions for fiscal 2025 was $181.00K, a 90.53% increase from fiscal 2024.
- CHAMPIONS ONCOLOGY, INC. tax adjustments, settlements, and unusual provisions for fiscal 2024 was $95.00K.
- CHAMPIONS ONCOLOGY, INC. tax adjustments, settlements, and unusual provisions for fiscal 2023 was -$95.00K.
| Period end | Tax Adjustments, Settlements, and Unusual Provisions 12 month |
|---|---|
| 2025-04-30 | $181.00K 10-K · filed 2026-07-27 |
| 2024-04-30 | $95.00K 10-K · filed 2025-07-23 |
| 2023-04-30 | -$95.00K 10-K · filed 2024-07-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |